ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

ACR Convergence 2026

November 6-11, 2026. Orlando, Florida.

View by Number View by Title View Sessions
  • Abstract Number: 0032

    Identification of Mitochondrial Autoantibody Signatures Associated with Cellular Bioenergetic Dysfunction in Systemic Sclerosis
  • Abstract Number: 0033

    IL-1β Primes Liver Receptor Homolog-1-Mediated Profibrotic Fibroblast Activation in Systemic Sclerosis
  • Abstract Number: 0034

    Longitudinal Multi-modal Analysis Uncovers Coordinated Immune and Stromal Modulation after CD19 CAR-T Cell Therapy in Systemic Sclerosis
  • Abstract Number: 0035

    Novel cytokine candidate, p40-EBI3 complex regulates profibrotic T cell and B cell and inhibits systemic sclerosis via simultaneous regulation of STAT3/STAT5 signals
  • Abstract Number: 0036

    Peripheral Blood Single-Cell RNA Sequencing Reveals Distinct Gene Signatures in Systemic Sclerosis Patients With and Without Interstitial Lung Disease
  • Abstract Number: 0037

    Serum KL-6 and ICAM-1 correlate with percent predicted forced vital capacity at baseline but not ongoing disease progression in individuals with systemic sclerosis associated interstitial lung disease
  • Abstract Number: 0038

    Spatial Orchestration of Skin Fibrosis by a CD8 T cell-Myofibroblast Axis
  • Abstract Number: 0039

    A single-cell atlas of >1 million blood and lymph node immune cells reveals peripheral and tissue immune reprogramming following CD3×CD19 T-cell engager therapy in active SLE
  • Abstract Number: 0040

    Blockade of Mechanistic Target of Rapamycin Complexes 1 and 2 across Anti-Inflammatory Tregs and Pro-Inflammatory CD8+ TEMRA, CD4+ Tfh, and Long-Lived Plasma Cells Underlies Therapeutic Action of N-acetylcysteine in Patients with Active Systemic Lupus Erythematosus
  • Abstract Number: 0041

    Comparison of Molecular Responses to Autologous and Allogeneic CD19 CAR-T Cell Therapy in Systemic Lupus Erythematosus
  • Abstract Number: 0042

    Complement C4 Haplotype and Dysbiosis Influence the Spectrum of Clinical Autoimmunity in Anti-SSA/Ro+ Mothers of Children with Neonatal Lupus
  • Abstract Number: 0043

    Decoupling Interferon and Neutrophil Gene Signatures in Systemic Lupus Erythematosus: A Cross-Sectional Transcriptomic Analysis
  • Abstract Number: 0044

    Integrative Multi-Omic Profiling of Lupus Nephritis Reveals MicroRNA Master Regulators of Immune Pathogenesis and Class-Specific Biomarkers
  • Abstract Number: 0045

    KBD051, a Novel and Highly Selective Oral TLR7/8 Antagonist, Demonstrates Prolonged Pharmacodynamic Activity and Profound Efficacy in Preclinical Models of Systemic Lupus Erythematosus
  • Abstract Number: 0046

    Metabolic-epigenetic regulation of interferon-responsive CD38 in systemic lupus erythematosus
  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 198
  • Next Page

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology